Low dose interleukin-2 ameliorates sjögren`s syndrome in a murine model

HIGHLIGHTS

• who: Jing He from the Department of Rheumatology and Immunology, Peking University People`s Hospital, Beijing, China have published the research work: Low Dose Interleukin-2 Ameliorates Sju00f6gren`s Syndrome in a Murine Model, in the Journal: (JOURNAL)
• what: This study provides preliminary evidence that LDIL-2 ameliorates inflammation of SS pathology in an experimental animal model.
• how: Showed that the amounts of saliva collected for 15 min after Frontiers in Medicine | www.frontiersin.org May 2022 | Volume 9 | Article 887354 Low-Dose IL-2 Ameliorates Sju00f6gren`s Syndrome Frontiers in Medicine | www . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.